0001388658-24-000003.txt : 20240104
0001388658-24-000003.hdr.sgml : 20240104
20240104115722
ACCESSION NUMBER: 0001388658-24-000003
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240102
FILED AS OF DATE: 20240104
DATE AS OF CHANGE: 20240104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wilson Daniel G.
CENTRAL INDEX KEY: 0001860745
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37918
FILM NUMBER: 24510684
MAIL ADDRESS:
STREET 1: 699 8TH STREET, SUITE 600
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: iRhythm Technologies, Inc.
CENTRAL INDEX KEY: 0001388658
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 208149544
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 699 8TH STREET
STREET 2: SUITE 600
CITY: San Francisco
STATE: CA
ZIP: 94103
BUSINESS PHONE: 415-632-5700
MAIL ADDRESS:
STREET 1: 699 8TH STREET
STREET 2: SUITE 600
CITY: San Francisco
STATE: CA
ZIP: 94103
FORMER COMPANY:
FORMER CONFORMED NAME: IRhythm Technologies, Inc.
DATE OF NAME CHANGE: 20110429
FORMER COMPANY:
FORMER CONFORMED NAME: IRhythm Technologies Inc
DATE OF NAME CHANGE: 20070201
4
1
wk-form4_1704387433.xml
FORM 4
X0508
4
2024-01-02
0
0001388658
iRhythm Technologies, Inc.
IRTC
0001860745
Wilson Daniel G.
C/O IRHYTHM TECHNOLOGIES, INC.
699 8TH ST #600
SAN FRANCISCO
CA
94103
0
1
0
0
EVP, Corp Dev Inv Rel
0
Common Stock
2024-01-02
4
S
0
7218
103.31
D
26629
D
These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of RSUs.
This transaction was executed in multiple trades at prices ranging from $100.55 to $103.34 per share. The price reported above reflects the weighted average sale price. The Reporting person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
/s/ Marc Rosenbaum, attorney-in-fact
2024-01-04